Eden Health Expands Personalized Care Platform Through Acquisition Of Contigo Compounding

Eden Health, the health platform that connects members with independent, licensed provider organizations for personalized health care, announced its acquisition of Contigo Compounding, a licensed 503A compounding pharmacy specializing in sterile and non-sterile custom medications. Financial terms were not disclosed.

Contigo's state-of-the-art facility, compliant with United States Pharmacopeia (USP) <797> and <800> guidelines, will allow Eden to handle all medication preparation internally, allowing for fully personalized treatments and real-time coordination with members and care teams, with batch sterility testing, real-time inventory tracking, and free next-day shipping, the announcement . . .